메뉴 건너뛰기




Volumn 16, Issue SUPPL. 1, 2002, Pages

Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry

Author keywords

International regulatory guidelines; Maximum tolerated dose; Positron emission tomography; Sequential cohort design

Indexed keywords

ALZHEIMER DISEASE; DRUG APPROVAL; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; INTERNATIONAL COOPERATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0036279781     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200200001-00006     Document Type: Review
Times cited : (6)

References (22)
  • 20
    • 0031454126 scopus 로고    scopus 로고
    • Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study
    • (1997) Neurology , vol.49 , pp. 1513-1521
    • Schuff, N.1    Amend, D.2    Ezekiel, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.